NKTR

Nektar Therapeutics (NKTR)

About Nektar Therapeutics (NKTR)

Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. The firm focuses on using new chemistry approaches to make medicines to treat cancer and autoimmune diseases. The company was founded in 1990 and is headquartered in San Francisco, CA.

Details

Daily high

$1.37

Daily low

$1.29

Price at open

$1.34

52 Week High

$1.93

52 Week Low

$0.41

Market cap

243.0M

Dividend yield

0.00%

Volume

786,452

Avg. volume

988,928

P/E ratio

-1.47

Nektar Therapeutics News